About Hasten Biopharma
ROOTED IN CHINA, THINKING GLOBALLY

Scroll down

ABOUT HASTEN BIOPHARMA

Hasten Biopharmaceutic Company Limited (Hasten Biopharma), which integrates R&D, production and commercial promotion and covers the whole industrial chain, was established in 2020. Hasten is jointly invested and established by  CBC Group, one of the largest healthcare-dedicated investment firms in Asia, Hefei Industry Investment Group and Feidong County, Hefei City.

Rooted in China with a global perspective, Hasten will connect the upstream and downstream industrial chains through the layout of "whole industry" and "globalization", as well as enrich product structure and pipelines by virtue of diversified ways and relying on the broad medical and health platform and resources of CBC Group. We will work closely with our stakeholders such as relevant government institutions, medical and health professionals and industry partners to continuously drive the management ecosystem of chronic diseases and geriatric-related diseases, aiming to build a leading innovative medical and healthcare enterprise in China so as to benefit more patients.

  • 6 offices & branches
  • 700+ talents
  • 2 overseas wholly-owned subsidiaries
  • 1 production base

CEO MESSAGE

Summer XIA - CEO of Hasten Biopharma

In less than 2 years since it was established, Hasten Biopharma quickly owned the commercialization rights of 5 originator drugs in China and built a team of over 700 people. In the future, Hasten Biopharma will continue to maintain a rapid development trend, follow the pulse of the times, rooted in China while looking at the world, through the "whole industry" and "globalization" layout, connecting the upstream and downstream industry chain, with a diversified approach to enrich our product portfolio and product pipeline, to achieve the goal of meeting the needs of healthcare professionals and patients, to create our own era of highlight.

With a well-established commercialization marketing network and professional marketing team, Hasten Biopharma is like a ship flying forward. We will strive to move forward in the blue ocean of health care by the ship of doctor-patient service, taking human health as the shore, innovation as the paddle, forging ahead as the sail.

OUR CULTURE

  • VISION
    VISION

    Establish professional talent team

    Provide high-quality treatment solutions

    Build health management ecosystem

    Be leader in the healthcare industry

  • MISSION
    MISSION

    Hospital-patient needs first

    Strive for excellence and perfection

    Serve the human health

  • VALUE
    VALUE

    Integrity

    Agility

    Innovation

    Ownership

  • AMBITIONS
    AMBITIONS

    In the future, the unmet medical needs in the field of chronic diseases and geriatric related diseases will be growing and generate large marketing potentials.

    Rooted in China with a global perspective, Hasten will connect the upstream and downstream industrial chains through the layout of "whole industry" and "globalization", as well as enrich product structure and pipelines by virtue of diversified ways and relying on the broad medical and health platform and resources of CBC Group.

    We will work closely with our stakeholders such as relevant government institutions, medical and health professionals and industry partners to continuously drive the management ecosystem of chronic diseases and geriatric-related diseases, aiming to build a leading innovative medical and healthcare enterprise in China so as to benefit more patients.

公司地址:这里是公司地址后期需要替换设计占位后台可替换

企业邮箱:infu@singlera.com.cn

联系电话:+86-8888-8888

商务联系:BD@singlera.com.cn

人力资源:HR@singlera.com.cn

×